Total Payments
$522,139
2024 Payments
$14,743
Companies
12
Transactions
80
Medicare Patients
105
Medicare Billing
$7,101
Payment Breakdown by Category
Royalty/License$348,152 (66.7%)
Consulting$64,458 (12.3%)
Travel$64,277 (12.3%)
Other$41,932 (8.0%)
Food & Beverage$2,351 (0.5%)
Education$850.45 (0.2%)
Gifts$118.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $348,152 | 2 | 66.7% |
| Consulting Fee | $64,458 | 18 | 12.3% |
| Travel and Lodging | $64,277 | 33 | 12.3% |
| Acquisitions | $29,510 | 2 | 5.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,365 | 2 | 2.4% |
| Food and Beverage | $2,351 | 18 | 0.5% |
| Education | $850.45 | 2 | 0.2% |
| Gift | $118.80 | 2 | 0.0% |
| Grant | $56.56 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic MiniMed, Inc. | $348,152 | 2 | $0 (2020) |
| Novo Nordisk AS | $89,420 | 44 | $0 (2020) |
| Medtronic, Inc. | $29,567 | 3 | $0 (2024) |
| Novo Nordisk Inc | $22,945 | 9 | $0 (2019) |
| Senseonics, Incorporated | $14,790 | 4 | $0 (2021) |
| Ascensia Diabetes Care US Inc. | $7,898 | 3 | $0 (2018) |
| ConvaTec Inc. | $6,720 | 5 | $0 (2022) |
| Lilly USA, LLC | $1,838 | 1 | $0 (2020) |
| Dexcom, Inc. | $308.26 | 4 | $0 (2024) |
| BETA BIONICS, INC. | $283.36 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,743 | 4 | Medtronic, Inc. ($14,499) |
| 2023 | $347.79 | 3 | BETA BIONICS, INC. ($283.36) |
| 2022 | $1,455 | 4 | ConvaTec Inc. ($1,280) |
| 2021 | $17,491 | 4 | Medtronic, Inc. ($15,011) |
| 2020 | $370,070 | 17 | Medtronic MiniMed, Inc. ($348,152) |
| 2019 | $39,444 | 21 | Novo Nordisk Inc ($22,945) |
| 2018 | $32,791 | 12 | Senseonics, Incorporated ($14,550) |
| 2017 | $45,796 | 15 | Novo Nordisk AS ($45,796) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $96.31 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Acquisitions | Cash or cash equivalent | $14,499.49 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 05/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $73.67 | General |
| Category: Endocrinology | ||||||
| 03/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $73.85 | General |
| Category: Endocrinology | ||||||
| 12/13/2023 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $98.23 | General |
| Category: Automated insulin delivery system | ||||||
| 12/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $64.43 | General |
| Category: Endocrinology | ||||||
| 05/16/2023 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $185.13 | General |
| Category: Automated insulin delivery system | ||||||
| 12/16/2022 | Mannkind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $59.40 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/15/2022 | Mannkind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $59.40 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/26/2022 | ConvaTec Inc. | AQUACEL AG+ (Device) | Consulting Fee | Cash or cash equivalent | $1,280.00 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 06/30/2022 | Medtronic, Inc. | MINIMED 770G (Device) | Grant | Cash or cash equivalent | $56.56 | General |
| Category: Durable Pump | ||||||
| 12/23/2021 | ConvaTec Inc. | AQUACEL Ag Advantage Surgical (Device) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Advanced Wound Care | ||||||
| 12/02/2021 | Medtronic, Inc. | InPen (Device) | Acquisitions | Cash or cash equivalent | $15,010.52 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 11/23/2021 | ConvaTec Inc. | AQUACEL Ag Advantage Surgical (Device) | Consulting Fee | Cash or cash equivalent | $640.00 | General |
| Category: Advanced Wound Care | ||||||
| 08/12/2021 | Senseonics, Incorporated | Eversense (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $240.00 | General |
| Category: Endocrinology | ||||||
| 12/15/2020 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $4,760.00 | General |
| 12/10/2020 | Medtronic MiniMed, Inc. | InPen (Device) | Royalty or License | Cash or cash equivalent | $66,506.23 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 09/22/2020 | Lilly USA, LLC | — | Consulting Fee | Cash or cash equivalent | $1,837.50 | General |
| 09/10/2020 | Medtronic MiniMed, Inc. | InPen (Device) | Royalty or License | Cash or cash equivalent | $281,645.47 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 08/20/2020 | Novo Nordisk AS | — | Education | Cash or cash equivalent | $175.70 | General |
| 07/03/2020 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $1,360.00 | General |
| 04/13/2020 | Novo Nordisk AS | Ryzodeg 70/30 (Drug) | Education | Cash or cash equivalent | $674.75 | General |
| Category: Diabetes | ||||||
| 04/13/2020 | Novo Nordisk AS | Ryzodeg 70/30 (Drug) | Travel and Lodging | In-kind items and services | $266.85 | General |
| Category: Diabetes | ||||||
| 04/13/2020 | Novo Nordisk AS | Ryzodeg 70/30 (Drug) | Food and Beverage | In-kind items and services | $72.88 | General |
| Category: Diabetes | ||||||
| 03/16/2020 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $4,675.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 29 | 60 | $10,204 | $2,512 |
| 2022 | 1 | 23 | 35 | $5,579 | $1,152 |
| 2021 | 1 | 25 | 35 | $5,600 | $1,161 |
| 2020 | 2 | 28 | 37 | $10,099 | $2,276 |
Total Patients
105
Total Services
167
Medicare Billing
$7,101
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 60 | $10,204 | $2,512 | 24.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 23 | 35 | $5,579 | $1,152 | 20.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 25 | 35 | $5,600 | $1,161 | 20.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $6,017 | $1,349 | 22.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 17 | 26 | $4,082 | $927.08 | 22.7% |
About Steven Russell, MD PHD
Steven Russell, MD PHD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679554042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Steven Russell, MD PHD has received a total of $522,139 in payments from pharmaceutical and medical device companies, with $14,743 received in 2024. These payments were reported across 80 transactions from 12 companies. The most common payment nature is "Royalty or License" ($348,152).
As a Medicare-enrolled provider, Russell has provided services to 105 Medicare beneficiaries, totaling 167 services with total Medicare billing of $7,101. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Boston, MA
- Active Since 11/10/2005
- Last Updated 11/07/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679554042
Products in Payments
- InPen (Device) $363,162
- Eversense (Device) $14,790
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $14,499
- FIASP (Drug) $7,368
- Ryzodeg 70/30 (Drug) $6,770
- AQUACEL AG (Device) $3,200
- AQUACEL Ag Advantage Surgical (Device) $2,240
- AQUACEL AG+ (Device) $1,280
- Dexcom G6 Transmitter (Medical Supply) $308.26
- iLet Bionic Pancreas (Device) $283.36
- AFREZZA (Drug) $118.80
- Dasiglucagon (Device) $100.00
- MINIMED 770G (Device) $56.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
Internal Medicine $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Internal Medicine $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Internal Medicine $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Internal Medicine $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M